IP Verse

Glycopeptide Compositions

Patent No. EP3215173 (titled "Glycopeptide Compositions") was filed by Xellia Pharmaceuticals APS on Nov 6, 2015. The application was issued on Mar 11, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
DF MP DORRIES FRANK MOLNIA & POHLMAN PATENTANWALTE RECHTSANWALTE PARG MBBOct 1, 2020EDER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3215173

XELLIA PHARMACEUTICALS APS
Application Number
EP15791287A
Filing Date
Nov 6, 2015
Status
Revoked
Jul 15, 2022
Publication Date
Mar 11, 2020
External Links
Slate, Register , Google Patents